Senescence during early differentiation reduced the chondrogenic differentiation capacity of mesenchymal progenitor cells
Introduction: Mesenchymal stromal/progenitor cells (MSCs) are promising for cartilage cell-based therapies due to their chondrogenic differentiation capacity. However, MSCs can become senescent during in vitro expansion, a state characterized by stable cell cycle arrest, metabolic alterations, and s...
Main Authors: | Chantal Voskamp, Wendy J. L. M. Koevoet, Gerjo J. V. M. Van Osch, Roberto Narcisi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1241338/full |
Similar Items
-
Enhanced Chondrogenic Capacity of Mesenchymal Stem Cells After TNFα Pre-treatment
by: Chantal Voskamp, et al.
Published: (2020-06-01) -
Effect of arthritic synovial fluids on the expression of immunomodulatory factors by mesenchymal stem cells: an explorative in-vitro study
by: Maarten J.C. Leijs, et al.
Published: (2012-08-01) -
Senescence induces fundamental changes in the secretome of mesenchymal stromal cells (MSCs): implications for the therapeutic use of MSCs and their derivates
by: Yesuf Siraj, et al.
Published: (2023-05-01) -
Modulating design parameters to drive cell invasion into hydrogels for osteochondral tissue formation
by: Andrea Schwab, et al.
Published: (2023-07-01) -
Galactose Enhances Chondrogenic Differentiation of ATDC5 and Cartilage Matrix Formation by Chondrocytes
by: Zhongrun Yuan, et al.
Published: (2022-05-01)